December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Protective Effect of Nilvadipine against Retinal Ischemia Studied by ERGs and TUNEL staining
Author Affiliations & Notes
  • A Uemura
    Department of Ophthalmology and Visual Science Graduate School of Medicine Chiba University Chiba Japan
  • A Mizota
    Department of Ophthalmology and Visual Science Graduate School of Medicine Chiba University Chiba Japan
  • E Sato
    Department of Ophthalmology and Visual Science Graduate School of Medicine Chiba University Chiba Japan
  • M Kubota
    Department of Ophthalmology and Visual Science Graduate School of Medicine Chiba University Chiba Japan
  • E Adachi-Usami
    Department of Ophthalmology and Visual Science Graduate School of Medicine Chiba University Chiba Japan
  • Footnotes
    Commercial Relationships   A. Uemura, None; A. Mizota, None; E. Sato, None; M. Kubota, None; E. Adachi-Usami, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 769. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A Uemura, A Mizota, E Sato, M Kubota, E Adachi-Usami; Protective Effect of Nilvadipine against Retinal Ischemia Studied by ERGs and TUNEL staining . Invest. Ophthalmol. Vis. Sci. 2002;43(13):769.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Nilvadipine, a dihydropyridine-type calcium channel blocker, is fat soluble and passes through the blood:brain barrier easily. It is a therapeutic drug for hypertension and ischemic cerebrovascular disease. It has been reported in glaucoma that calcium blockers can protect retinal ganglion cells (RGCs). The purpose of this study was to determine whether nilvadipine will protect the retina against ischemia-reperfusion injury in rats. Methods: Eight week-old Wister rats (200 g) were anesthetized with pentobarbital sodium. Initially, 0.3 ml nilvadipine (0.5 mg/ml in polyethylene glycol 400) was injected intramusculary. Control rats received the same amount of polyethylene glycol 400. Ten minutes after the injection, the anterior chamber was cannulated and the intraocular pressure was increased to 120 mmHg and maintained for 45 minutes. During the pressure elevation, the body temperature was kept at 37° C. Before and 7 days after the ischemia, the amplitudes of the a- and b-waves of the ERGs were evaluated. One day after the ischemia, apoptosis was determined by TUNEL staining, and at 7 days, the number of RGCs was counted in paraffin sections. Results: There was no significant difference in the ERG amplitudes between the two groups. However, there were fewer TUNEL-positive cells especially in the RGC layer in the nilvadipine group, and the number of RGCs was significantly greater in the nilvadipine-treated animals. Conclusion: These results indicate that nilvadipine has a neuroprotective effect for retinal ganglion cells against retinal ischemia.

Keywords: 489 neuroprotection • 448 ischemia • 390 drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×